Publications by authors named "Jan Fagius"

Claim this Profile
H
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
Thomas Silfverberg, Christina Zjukovskaja, Per Ljungman, Adjmal Nahimi, Erik Ahlstrand, Jan Fagius

J Neurol Neurosurg Psychiatry· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family.
Jan Fagius, Joakim Klar, Niklas Dahl

Clin Auton Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.
Andreas Tolf, Jan Fagius, Kristina Carlson, Torbjörn Åkerfeldt, Tobias Granberg

Acta Neurol Scand· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Richard K Burt, Roumen Balabanov, Joachim Burman, Basil Sharrack, John A Snowden, Jan Fagius

JAMA· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Jan Fagius

Lakartidningen· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab.
Jan Fagius, Amalia Feresiadou, Elna-Marie Larsson, Joachim Burman

Mult Scler Relat Disord· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention.
Joachim Burman, Emma Svensson, Moa Fransson, Angelica S I Loskog, Henrik Zetterberg, Jan Fagius

J Neuroimmunol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Joachim Burman, Ellen Iacobaeus, Anders Svenningsson, Jan Lycke, Martin Gunnarsson, Jan Fagius

J Neurol Neurosurg Psychiatry· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Joachim Burman, Moa Fransson, Thomas H Tötterman, Jan Fagius, Sara M Mangsbo

Immunology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High resting level and weak response of baroreflex-governed sympathetic outflow in amyotrophic lateral sclerosis.
Ingela Nygren, Jan Fagius

Muscle Nerve· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T regulatory cells lacking CD25 are increased in MS during relapse.
Moa Fransson, Joachim Burman, Camilla Lindqvist, Christina Atterby, Jan Fagius

Autoimmunity· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong potential for baroreflex-governed sympathetic outflow revealed during nausea.
Jan Fagius, Ingela Nygren

Clin Auton Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The T-cell pool is anergized in patients with multiple sclerosis in remission.
Moa E Fransson, Lina S E Liljenfeldt, Jan Fagius, Thomas H Tötterman, Angelica S I Loskog

Immunology· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hematopoietic stem cell transplantation in MS. Justified, and if so, when?].
Jan Fagius, Gunnar Oberg

Lakartidningen· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[TGA: Clinical assessment is sufficient in the investigation!].
Jan Fagius

Lakartidningen· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Disease-modifying treatment of MS--progress with complications].
Jan Fagius

Lakartidningen· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sympathetic nerve activity to amputated lower leg in humans. Evidence of altered skin vasoconstrictor discharge.
Jan Fagius, Magnus Nordin, Magnus Wall

Pain· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trial.
Joep Killestein, Tomas Olsson, Erik Wallström, Anders Svenningsson, Mohsen Khademi, Jan Fagius

Ann Neurol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis